Last chance: 3rd Annual Startup Symposium – Day 3

Join us on our last day (Nov. 10th, 10-12:30 am EST) of the 3rd Annual Biotech Startup Symposium. Today`s agenda will focus on two very important aspects for emerging biotechs: partnerships and funding. Enjoy two speeches and a panel discussion with CEO`s from the industry who will share their view on the current state of the market, talk about trends and challenges and share their experience as CEO`s with the audience. Agenda: • The Current State of Emerging Biotech Venture Capital & How to Successfully Raise Funds (Dr. Anique ter Braake, Biotechnology Associate Analyst, M Ventures) • Breeding Biotechs in a Comprehensive Cancer Center: from Bench to Bedside (Loic Sebileau, Technology Transfer Officer & Industrial Partnership Manager, Leon Berard Comprehensive Cancer Center (CLB) & Cancer Research Center of Lyon and Nathalie Donne, Co-CEO of ErVaccine) • Panel Discussion “Voice of the CEO” moderated by Manuel Kretschmer, Head of Strategy, BioProcessing Panel participants: Dirk Lange, Head of Life Science Services; Jolly Mazumdar, Founding CEO, Chimeron; Peter van de Sande, CEO, Synaffix; Jérémie Laurent, Founding CEO, Astraveus Register here to join this last day of the 3rd Annual Biotech Startup Symposium and learn about latest trends in funding and the Emerging Biotech landscape.